Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 104

Sort by

Sort Order Select

Meeting Abstracts

1723-P: Dual-Label Kinetic Assay to Monitor ß-Cell Death and Proliferation

LIORA S. KATZ, PENG WANG, HUSNU U. KANISKAN, JESSE D. GELLES, JERRY EDWARD CHIPUK, ANDREW F. STEWART, DONALD SCOTT

Diabetes 2023;72(Supplement_1):1723-P

https://doi.org/10.2337/db23-1723-P

Published: 20 June 2023

View article titled, 1723-P: Dual-Label Kinetic Assay to Monitor ß-Cell Death and Proliferation

Meeting Abstracts

585-P: Lactate Kinetics in Type 1 Diabetes—A 1-13C Lactate Study

DAVIDE ROMERES, FNU RUCHI, YOGESH YADAV, CLAUDIO COBELLI, ANANDA BASU, RITA BASU

Diabetes 2023;72(Supplement_1):585-P

https://doi.org/10.2337/db23-585-P

Published: 20 June 2023

View article titled, 585-P: Lactate Kinetics in Type 1 Diabetes—A 1-13C Lactate Study

Meeting Abstracts

55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

XI CHEN, CAROLINA SOLIS-HERRERA, DEVJIT TRIPATHY, ANDREA A. HANSIS-DIARTE, ROBERT CHILTON, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2022;71(Supplement_1):55-LB

https://doi.org/10.2337/db22-55-LB

Published: 01 June 2022

View article titled, 55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

Meeting Abstracts

264-OR: Glucagon Kinetics: Model from First-in-Humans with 13C15N Glucagon

MICHELE SCHIAVON, FNU RUCHI, YOGESH R. YADAV, RITA BASU, CLAUDIO COBELLI, CHIARA DALLA MAN, ANANDA BASU

Diabetes 2021;70(Supplement_1):264-OR

https://doi.org/10.2337/db21-264-OR

Published: 01 June 2021

View article titled, 264-OR: Glucagon Kinetics: Model from First-in-Humans with 13C15N Glucagon

Meeting Abstracts

87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001

YUSMAN MANCHANDA, BEN JONES, GAELLE CARRAT, ZENOUSKA RAMCHUNDER, PIERO MARCHETTI, ISABELLE LECLERC, RAJAMANNAR THENNATI, VINOD S. BURADE, ALEJANDRA TOMAS, GUY A. RUTTER

Diabetes 2021;70(Supplement_1):87-LB

https://doi.org/10.2337/db21-87-LB

Published: 01 June 2021

View article titled, 87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001

Meeting Abstracts

1772-P: Reversibility of Altered Brain Glucose Kinetics in T2DM

ELIZABETH SANCHEZ RANGEL, FELONA GUNAWAN, LIHONG JIANG, MARY SAVOYE, FENG DAI, DOUGLAS L. ROTHMAN, GRAEME F. MASON, JANICE J. HWANG

Diabetes 2020;69(Supplement_1):1772-P

https://doi.org/10.2337/db20-1772-P

Published: 01 June 2020

View article titled, 1772-P: Reversibility of Altered Brain Glucose Kinetics in T2DM

Meeting Abstracts

1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

MARIAM ALATRACH, CHRISTINA AGYIN, IV, NITCHAKARN LAICHUTHAI, OLGA LAVRYNENKO, JOHN M. ADAMS, II, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO

Diabetes 2020;69(Supplement_1):1136-P

https://doi.org/10.2337/db20-1136-P

Published: 01 June 2020

View article titled, 1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

Meeting Abstracts

1793-P: C-Peptide Kinetics: The Van Cauter Population Model May Not Be Applicable to Post–Gastric Bypass Adults with Postprandial Hyperinsulinemic Hypoglycemia

MICHELE SCHIAVON, DAVID HERZIG, MATTHIAS HEPPRICH, MARC Y. DONATH, CHRISTOPH STETTLER, LIA BALLY, CHIARA DALLA MAN

Diabetes 2020;69(Supplement_1):1793-P

https://doi.org/10.2337/db20-1793-P

Published: 01 June 2020

View article titled, 1793-P: C-Peptide Kinetics: The Van Cauter Population Model May Not Be Applicable to Post–Gastric Bypass Adults with Postprandial Hyperinsulinemic Hypoglycemia

Meeting Abstracts

573-P: Construction and Validation of a Hierarchical-Driven Network for Decoding the Potential Molecular Mechanisms in Diabetic Microvascular Complications

HAICHENG LI, XIANAN FU, XUEMIN HE, RONGDONG PENG, YUANPENG NIE, TING LI, YANMING CHEN

Diabetes 2020;69(Supplement_1):573-P

https://doi.org/10.2337/db20-573-P

Published: 01 June 2020

View article titled, 573-P: Construction and Validation of a Hierarchical-Driven Network for Decoding the Potential Molecular Mechanisms in Diabetic Microvascular Complications

Meeting Abstracts

2100-P: Binding Kinetics, GLP-1 Receptor Internalization, and Effects on Insulin Secretion for GL0034 and Related GLP-1R Agonists

GAELLE CARRAT, MARIE-SOPHIE NGUYEN-TU, ISABELLE LECLERC, RAJAMANNAR THENNATI, BEN JONES, ALEJANDRA TOMAS, GUY A. RUTTER

Diabetes 2020;69(Supplement_1):2100-P

https://doi.org/10.2337/db20-2100-P

Published: 01 June 2020

View article titled, 2100-P: Binding Kinetics, GLP-1 Receptor Internalization, and Effects on Insulin Secretion for GL0034 and Related GLP-1R Agonists

Meeting Abstracts

1836-P: Derivation of Glucagon Kinetics to Reconstruct Glucagon Secretion in Nondiabetic Humans

MARCELLO C. LAURENTI, CHIARA DALLA MAN, J.D. ADAMS, AOIFE M. EGAN, CLAUDIO COBELLI, ADRIAN VELLA

Diabetes 2019;68(Supplement_1):1836-P

https://doi.org/10.2337/db19-1836-P

Published: 01 June 2019

View article titled, 1836-P: Derivation of Glucagon Kinetics to Reconstruct Glucagon Secretion in Nondiabetic Humans

Journal Articles

Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo

Ian M. Williams, P. Mason McClatchey, Deanna P. Bracy, Francisco A. Valenzuela, David H. Wasserman

Diabetes 2018;67(10):1962–1975

https://doi.org/10.2337/db18-0288

Published: 12 July 2018

View article titled, Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo

Includes: Supplementary data

Meeting Abstracts

Effects of NAFLD on Acetyl-CoA Partitioning and Ketone Kinetics in Response to a 24-Hour Fast

JUSTIN A. FLETCHER, STANISLAW DEJA, SHAWN C. BURGESS, JEFFREY BROWNING

Diabetes 2018;67(Supplement_1):47-OR

https://doi.org/10.2337/db18-47-OR

Published: 01 July 2018

View article titled, Effects of NAFLD on Acetyl-CoA Partitioning and Ketone Kinetics in Response to a 24-Hour Fast

Meeting Abstracts

Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in T2D Patients Treated with Dapagliflozin plus Saxagliptin Combination

YUEJUAN QIN, JOHN M. ADAMS, II, ROBERT A. MARTINEZ, ANTONINO DI PINO, HUSSEIN AL JOBORI, ALI M. ALI, CURTIS L. TRIPLITT, RALPH A. DEFRONZO, EUGENIO CERSOSIMO

Diabetes 2018;67(Supplement_1):1192-P

https://doi.org/10.2337/db18-1192-P

Published: 01 July 2018

View article titled, Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in T2D Patients Treated with Dapagliflozin plus Saxagliptin Combination

Meeting Abstracts

In Vitro Studies to Evaluate the Receptor Kinetics of Efpeglenatide vs. Other Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists

IN YOUNG CHOI, MI JIN MOON, MICHAEL E. TRAUTMANN, MARCUS HOMPESCH, CHRISTOPHER H. SORLI

Diabetes 2018;67(Supplement_1):1090-P

https://doi.org/10.2337/db18-1090-P

Published: 01 July 2018

View article titled, In Vitro Studies to Evaluate the Receptor Kinetics of Efpeglenatide vs. Other Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists

Meeting Abstracts

Efficacy of Average Daily Risk Range (ADRR) to Estimate Glycemic Kinetics during Nighttime in Japanese Patients with Type 1 Diabetes Mellitus

FUKI IKEDA, AKIO KANAZAWA, MAYU IIDA, HIDEYOSHI KAGA, NAOKO TAKAYANAGI, TOMOAKI SHIMIZU, CHIE SHIRAKAWA, HIROTAKA WATADA

Diabetes 2018;67(Supplement_1):928-P

https://doi.org/10.2337/db18-928-P

Published: 01 July 2018

View article titled, Efficacy of Average Daily Risk Range (ADRR) to Estimate Glycemic Kinetics during Nighttime in Japanese Patients with Type 1 Diabetes Mellitus

Meeting Abstracts

Intradermal Administration Improves the Kinetics of Faster-Acting Fiasp® Insulin

SAHAN RANAMUKHA, IMAN MANSOOR, KIMBERLEY FENG, BORIS STOEBER, MOHAMED WEHBE, RORY ST CLAIR, CLAUDE PICHE, JEAN-PIERRE MOREAU

Diabetes 2018;67(Supplement_1):985-P

https://doi.org/10.2337/db18-985-P

Published: 01 July 2018

View article titled, Intradermal Administration Improves the Kinetics of Faster-Acting Fiasp® Insulin

Journal Articles

Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes

Maka S. Hedrington, Maia Mikeladze, Donna B. Tate, Lisa M. Younk, Ian Davis, Stephen N. Davis

Diabetes 2016;65(9):2754–2759

https://doi.org/10.2337/db16-0207

Published: 23 May 2016

View article titled, Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes

Journal Articles

Differences in In Vivo Cellular Kinetics in Abdominal and Femoral Subcutaneous Adipose Tissue in Women

Ursula A. White, Mark D. Fitch, Robbie A. Beyl, Marc K. Hellerstein, Eric Ravussin

Diabetes 2016;65(6):1642–1647

https://doi.org/10.2337/db15-1617

Published: 18 March 2016

View article titled, Differences in In Vivo Cellular Kinetics in Abdominal and Femoral Subcutaneous Adipose Tissue in Women

Journal Articles

Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes

W. Todd Cade, Rachel A. Tinius, Dominic N. Reeds, Bruce W. Patterson, Alison G. Cahill

Diabetes 2016;65(4):893–901

https://doi.org/10.2337/db15-1061

Published: 09 February 2016

View article titled, Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes

NARROW

1723-P: Dual-Label Kinetic Assay to Monitor ß-Cell Death and Proliferation

585-P: Lactate Kinetics in Type 1 Diabetes—A 1-13C Lactate Study

55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

264-OR: Glucagon Kinetics: Model from First-in-Humans with 13C15N Glucagon

87-LB: Binding Kinetics, Bias, Receptor Internalization, and Effects on Insulin Secretion for a Novel GLP1R-GIPR Dual Agonist, HISHS-2001

1772-P: Reversibility of Altered Brain Glucose Kinetics in T2DM

1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes

1793-P: C-Peptide Kinetics: The Van Cauter Population Model May Not Be Applicable to Post–Gastric Bypass Adults with Postprandial Hyperinsulinemic Hypoglycemia

573-P: Construction and Validation of a Hierarchical-Driven Network for Decoding the Potential Molecular Mechanisms in Diabetic Microvascular Complications

2100-P: Binding Kinetics, GLP-1 Receptor Internalization, and Effects on Insulin Secretion for GL0034 and Related GLP-1R Agonists

1836-P: Derivation of Glucagon Kinetics to Reconstruct Glucagon Secretion in Nondiabetic Humans

Acute Nitric Oxide Synthase Inhibition Accelerates Transendothelial Insulin Efflux In Vivo

Effects of NAFLD on Acetyl-CoA Partitioning and Ketone Kinetics in Response to a 24-Hour Fast

Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in T2D Patients Treated with Dapagliflozin plus Saxagliptin Combination

In Vitro Studies to Evaluate the Receptor Kinetics of Efpeglenatide vs. Other Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists

Efficacy of Average Daily Risk Range (ADRR) to Estimate Glycemic Kinetics during Nighttime in Japanese Patients with Type 1 Diabetes Mellitus

Intradermal Administration Improves the Kinetics of Faster-Acting Fiasp® Insulin

Effects of γ-Aminobutyric Acid A Receptor Activation on Counterregulatory Responses to Subsequent Exercise in Individuals With Type 1 Diabetes

Differences in In Vivo Cellular Kinetics in Abdominal and Femoral Subcutaneous Adipose Tissue in Women

Maternal Glucose and Fatty Acid Kinetics and Infant Birth Weight in Obese Women With Type 2 Diabetes

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only